In mammals, Atg5 can induce cell cycle arrest at the G1/S phase by up-regulating expression of p21 (a cyclin-dependent kinase inhibitor) at the level of post-transcription in response to challenges such as nutrient deficiency (42, 43). Here, ATG5 is linked to hyperinsulinemic hypoglycemia, familial, 4.